Ten Practice Changes I Will Make After Attending ASCO 2011

2011 Jun 28, Jeffrey Kirshner, MD

Abstract

Dr. Jeffrey Kirshner is Partner and Director of Research, Hematology Oncology Associates of Central New York, East Syracuse, and Chief of Oncology, Community General Hospital, Syracuse, NY. For more information about Dr. Kirshner, view his profile. As I prepare my list this year, I’ve looked back at my report from the last several years, and I’ve made most of the changes, as predicted. Just in the past year, many of these changes have benefited my patients, including utilizing FOLFIRINOX in treating...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration